CFO Craig Phillips will leave Purple Innovation on August 31. Phillips was appointed finance chief of the mattress manufacturer in October 2019 after serving as interim CFO since March 2019. Before that, he was a managing director at FTI Consulting. The company has appointed Bennett Nussbaum to serve as interim CFO while it looks for a permanent replacement. Nussbaum is a global financial executive and senior adviser with over 45 years of experience, including roles as CFO at Pepsi-Cola International, Burger King, and FedEx Office.
Jeff Gruener was appointed senior vice president and chief financial officer of Walgreens. Most recently, Gruener worked at Walmart, where he served in a number of roles of increasing responsibility over his 12 years with the company, including senior vice president of finance and strategy, senior vice president of merchandising operations, vice president of finance for Sam’s Club, and vice president of global procurement. Before Walmart, he worked at Sears Holdings, serving in a variety of business development, strategy, and marketing roles. He also previously held business roles at Ernst & Young and Honeywell.
Wella Company named Virginie Costa as the beauty company’s new global chief financial officer. Most recently, Costa was CFO of Godiva. She was previously chief financial and operations officer for Burberry Americas and chief financial officer and chief operating officer of Hermes in France and Americas. She is also a member of the board of directors of Advantage Solutions, a global communications and media company, where she chairs the audit committee.
E-commerce company Pharmapacks hired Andreas Schulmeyer as chief financial officer. Schulmeyer was previously head of e-commerce international for L Brands and CFO of Walmart e-commerce. He also brings experience from his prior roles as CFO for Better Choice Company and PepsiCo Asia Beverages. He returns to the C-suite after seven years at Faultline Solutions, an e-commerce consulting firm he founded in 2014.
Pharmaceutical company Neurogastrx named Jim DeTore as chief financial officer. DeTore was previously CFO of Bluebird Bio, where he helped raise over $800 million in capital. Before that, he was vice president of finance at Ironwood Pharmaceuticals, where he worked on its initial public offering and follow-on rounds of financing.
IT services and solution provider ATSG appointed Jeanne Walters as finance chief. Walters joins the company from TrueCore Behavioral Solutions, where she was chief financial officer. She has previous executive leadership responsibility for financial operations in several private equity sponsored companies, such as Pegasus Transtech and Sage Software. Walters succeeds Ron Zampolin, who has been promoted to president of corporate development.
Unbounce named Greg Dos Santos as chief financial officer. Dos Santos joins the software company with over 20 years of financial leadership experience in the technology industry for growing software as a service (SaaS) and professional services companies. Previously, Dos Santos was Cardinal Path’s CFO, where he led the sale to Dentsu. Before Cardinal Path, he was the vice president of finance at Blast Radius and the director of finance at Maximizer Software.
Institute of Management Accountants (IMA) named Russ Porter as CFO and senior vice president of strategy, technology, and analytics. Porter has been a member of IMA for more than 25 years and previously worked at IBM for more than 28 years, most recently as vice president of finance, global business services. His career spanned multiple business units and functions in the company, primarily in accounting and financial planning and analysis.
Neuromod USA hired Stephanie Glowacki as the medical device company’s new CFO. Glowacki joins the company from WS Audiology, where she held positions in finance, sales operations, and was chief of staff to the wholesale CEO. Before that, she held positions of increasing responsibility in sales operations and corporate finance at Sivantos, Phonak, Tellabs, and Andersen Consulting/Accenture.
Douglas Larson was appointed CFO of medical device and biopharmaceutical company Beyond Air. Larson recently served as vice president of finance and head of global controlling at biopharmaceutical company DBV Technologies. Before that, he was the CFO of The Scotts Miracle-Gro Company’s international division. Larson replaces Douglas Beck, who will remain a consultant to the company.
Linda Huber will take over as finance chief at financial information company FactSet in early October. Huber most recently was chief financial officer of MSCI and before that she worked at Moody’s, where she was executive vice president and chief financial officer. She succeeds Helen Shan, who has taken leadership of FactSet’s sales organization as chief revenue officer.